Financials

  • Market Capitalization 279.59 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.14
市销率
26.03

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3295
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.75 USD-0.53%+0.81%-1.83%-56.40%286.11 M USD
3311
ABEO
Abeona Therapeutics Inc. - Common Stock
4.90 USD-0.81%-5.04%-9.43%-8.07%280.20 M USD
3314
PALI
Palisade Bio, Inc. - Common Stock
1.59 USD+3.25%+5.30%-22.44%-6.47%277.09 M USD
3319
NAUT
Nautilus Biotechnology, Inc. - Common Stock
2.17 USD-3.56%+16.04%+114.85%+138.46%276.14 M USD

新闻